Kreft, Andreas; Schulze, Lisa; Ries, Isabelle et al.
Histological diagnosis of acute graft-versus-host disease in different sites of the upper gastrointestinal tract with correlation to endoscopic findingsLEUKEMIA & LYMPHOMA. 2022
Singh, Shuchi Agrawal; Bagri, Jaana; Giotopoulos, George et al.
HOXA9 Nucleates a Repressive Chromatin Complex with Nuclear Matrix-Associated Protein- Safb to Maintain Acute Myeloid LeukemiaBLOOD. Bd. 140. 2022
Beyer, Mandy; Henninger, Sven J.; Haehnel, Patricia S. et al.
Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cellsCELL CHEMICAL BIOLOGY. Bd. 29. H. 3. 2022 S. 398-+
Dreger, Peter; Holtick, Udo; Subklewe, Marion et al.
Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experienceBONE MARROW TRANSPLANTATION. 2022
Gobel, Sebastian; Hobohm, Lukas; Desuki, Alexander et al.
Impact of cardiac amyloidosis on outcomes of patients hospitalized with heart failureEUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 102. 2022 S. 88-96
Vogelmeier, Claus F.; Worth, Heinrich; Buhl, Roland et al.
Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' studyRESPIRATORY RESEARCH. Bd. 23. H. 1. 2022
Nowakowski, Grzegorz S.; Yoon, Dok Hyun; Peters, Anthea et al.
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort StudyCLINICAL CANCER RESEARCH. Bd. 28. H. 18. 2022 S. 4003-4017
Platzbecker, Uwe; Goetze, Katharina S.; Kiewe, Philipp et al.
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS StudyJOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 33. 2022 S. 3800-+
Ferreri, Andres J. M.; Cwynarski, Kate; Pulczynski, Elisa et al.
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trialLEUKEMIA. Bd. 36. H. 7. 2022 S. 1870-1878
Dreyling, Martin; Goy, Andre; Hess, Georg et al.
Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-upHEMASPHERE. Bd. 6. H. 5. 2022